Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Implementation Research on the LILAC Method to Educate Management of Elevated Lipoprotein(a).

NCT07177612 is registered in ClinicalTrials.gov with Changi General Hospital as lead sponsor.

NCT NCT07177612
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07177612 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Implementation Research on the LILAC Method to Educate Management of Elevated Lipoprotein(a).
Lead sponsor
Changi General Hospital
Phase
Observational
Overall status
Enrolling by invitation
Start date
September 9, 2025
Completion date
December 31, 2028
Enrollment
20,000 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

lipoprotein(a), lipoprotein(a), hyper-lp(a)-emia